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Background
Tuberculosis causes 2 million deaths per year and is the
most important opportunistic infection in patients
infected with HIV. During the co-infection of HIV/TB, nat-
ural regulatory T cells (CD4+ FOXP3+) down regulate
Th1/Th2 responses. Our study analysed the regulatory T-
cell phenotypes amongst participants dually infected with
HIV/TB, HIV or TB alone and healthy HIV negative con-
trols and used it as the basis for analysing anti-TB
responses and gene expression in HIV infected partici-
pants.
Methods
We performed direct ex vivo phenotyping of whole blood
with monoclonal antibodies to CD4, CD25, FOXP3,
CD38 and PD-1. In a 7-day whole blood assay, diluted
blood was incubated with TB proteins. The supernatant
was removed and analysed for Interferon-gamma produc-
tion by ELISA. The Multiplexed Ligation dependent Probe
Amplification technique was used to amplify ex vivo RNA
and compare gene expression of 45 genes.
Results
We found an increase in the ratio and frequency of regu-
latory T-cells in HIV/TB co-infected participants. PD-1
expression on highly activated T-cells was increased in
participants infected with HIV or TB alone. The median
Interferon-gamma responses to control TB antigens
(ESAT-6/CFP10, TB10.4, Ag85A, TB10.3) were the highest
in the controls. The response to p24 was higher in the
HIV+ group than the HIV-TB participants. The FOXP3
gene was significantly upregulated in HIV/TB co-infected
participants.
Conclusion
Participants with HIV/TB co-infection have significantly
more regulatory T-cells than those infected with either
HIV or TB which leads to a dampened immune response
to both HIV and TB. Differential gene expression and
increased frequencies of regulatory T-cells in the HIV/TB
co-infected participants may have important implications
for future vaccine designs. A more precise characterization
of the gene and cellular factors is needed in our attempt to
unravel the mechanisms of immune failure which is
present during HIV/TB co-infection.
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